Dimitris Papanicolaou

Empowering AI assisted clinical drug development: tactics to address data bias, the digital divide and missing patient populations through AI and digital solutions

The use of AI methodologies in drug development holds great potential to expedite clinical trials by helping to identify patients most likely to respond favorably to a given medication. To fully harness the benefits of such algorithmic approaches to precision medicine however requires that the datasets from which such...